Digital Genome Market forecast to grow at 9.5% CAGR from 2016 to 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Digital Genome Market forecast to grow at 9.5% CAGR from 2016 to 2024

Description:

Get more details @ Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference. – PowerPoint PPT presentation

Number of Views:48

less

Transcript and Presenter's Notes

Title: Digital Genome Market forecast to grow at 9.5% CAGR from 2016 to 2024


1
Research and Development led the Digital Genome
Market share to exceed 23bn by 2024 Global
Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Digital Genome Market
  • On-going research activities along with
    supportive regulations across the globe will
    revolutionize digital genome market.
  • The growing implementation of this technology in
    the field of personalized medical care for
    efficient disease management will noticeably
    favor digital genome industry share.
  • The prominent applications of digital genome
    industry are microbiology, reproductive
    genetic, research development, transportation,
    and livestock agriculture sectors.
  • Microbiology application segment accounted for
    more than 22 of the revenue share in 2015 and
    will surpass a revenue collection of USD 10
    billion by 2024.
  • Research development dominated the application
    landscape in 2015 and will contribute a revenue
    of more than USD 23 billion by 2024.
  • Sequencing and analysis software, one of the
    product bifurcations of digital genome market,
    will register an annual growth rate of 9.8 over
    the period of 2016 to 2024, owing to the
    increasing efforts to upgrade software packages.

3
Continued...
  • China digital genome market size will grow at an
    annual growth rate of more than 10 over the
    period of 2016 to 2024.
  • U.S. digital genome market covered over 80 of
    the North America regional share in 2015 and will
    generate significant revenue over the coming
    seven years, owing to the genome sequencing
    technological enhancements along with
    availability of advanced healthcare
    infrastructure.
  • Brazil digital genome market is anticipated to
    record a considerable growth rate over the coming
    timeframe. The supportive rules and regulations
    regarding genetic and clinical testing will
    augment the business growth.
  • Russia digital genome market collected a revenue
    of around USD 290 million in 2015 and will
    exhibit lucrative growth over the coming years of
    2016 to 2024, primarily driven by the fierce
    competition prevalent in the region.
  • The corporations operating in digital genome
    market are Becton Dickinson, Agilent
    Technologies, Qiagen, Thermo Fisher Scientific,
    Illumina, Pacific Biosciences, Perkin Elmer,
    Sigma-Aldrich, BioMarin Pharmaceutical, Fluidigm
    Corporation, Bio-Reference Laboratories, AVEO
    Oncology, and Agios.

4
Germany Digital Genome Market size, by product,
2012-2024 (USD Million)

5

Browse Full Market Research Report On Digital
Genome Market _at_ http//bit.ly/2oqb3Xv
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/1219 https//www.gminsights.com/request-sample/de
tail/49
6
Table of Content
Chapter 1. Methodology and Scope 1.1.
Methodology 1.1.1. Initial data
exploration 1.1.2. Statistical model
forecast 1.1.3. Industry insights
validation 1.1.4. Scope, definitions research
assumptions 1.2. Data Sources 1.2.1.
Primary 1.2.2. Secondary Chapter 2. Executive
Summary 2.1. Digital Genome industry 3600
synopsis, 2012 2024 (USD Million) 2.1.1.
Business trends 2.1.2. Product trends 2.1.3.
Application trends 2.1.4. End-use
trends 2.1.5. Regional trends
7
Table of Content
Chapter 3. Digital Genome Industry
Insights 3.1. Industry segmentation 3.2.
Industry size and forecast, 2012 2024 (USD
Million) 3.3. Industry impact forces 3.3.1.
Growth drivers 3.3.1.1. Successful completion
of the Human Genome Project 3.3.1.2.
Increasing public-private investments, funds, and
grants 3.3.1.3. Advances in
biotechnology 3.3.1.4. Increased Application
in clinical diagnosis 3.3.1.5. Rising use of
personalized medicine 3.3.1.6. Rise in
incidence and prevalence of chronic
diseases 3.3.1.7. Reduced cost and high speed
for DNA sequencing
8
Table of Content
3.3.2. Industry pitfalls challenges 3.3.2.1
. Unclear ROI of precision medicine 3.3.2.2.
Lack of trained staff 3.4. Growth potential
analysis 3.5. Porter's analysis 3.6.
Technology landscape 3.6.1. Advent of novel
technologies 3.7. Company market share
analysis, 2015 3.7.1. Strategy dashboard 3.8.
PESTEL analysis
9
Stay In Touch Website www.gminsights.com Soci
al Media
Write a Comment
User Comments (0)
About PowerShow.com